Allergan, known for its facial aesthetics, plastic surgery, and regenerative medicine business, has acquired Keller Medical, Inc, a privately held medical device company and developer of the Keller Funnel. The funnel is a cone that limits the doctor and patient contact during breast augmentation. The funnel was first developed in 2009 and a second version launched in 2014.
"Allergan is focused on providing technologies and products to help our surgeon customers improve procedures and Keller Funnel is that product for breast augmentation and reconstruction procedures," said David Moatazedi, senior vice president of Medical Aesthetics at Allergan. "The Keller Funnel was developed and designed by pioneering surgeons to improve breast implantation, and reduce the risks of implant contamination during procedures. This is a natural complement to our world-class plastic surgery and regenerative medicine business, and marketing this innovative device further enhances our commitment to our customers and patients."
The funnel was first developed in 2009 and a second version launched in 2014.
"The purchase of Keller Medical demonstrates Allergan's ongoing commitment to excellence in breast augmentation and reconstruction surgery," said Louis P. Bucky, M.D., clinical professor of surgery, division of plastic surgery at the University of Pennsylvania School of Medicine and chief of plastic surgery at Pennsylvania Hospital. "The Keller Funnel has become an innovative component to deliver the highest level of care for my cosmetic and reconstructive breast implant patients."